[AEONCR] YoY TTM Result on 31-Aug-2018 [#2]

Stock
[AEONCR] AEON CREDIT SERVICE (M) BHD
Announcement Date
04-Oct-2018
Admission Sponsor
-
Sponsor
-
Financial Year
28-Feb-2019
Quarter
31-Aug-2018 [#2]
Profit Trend
QoQ- 2.86%
YoY- 13.06%
Quarter Report
Latest QR
Upcoming QR
AEONCR's Result
AEONCR's Financial Summary
View:
Show?
TTM Result
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
Revenue 1,593,256 1,564,980 1,491,067 1,279,328 1,184,793 1,047,350 706,331 14.50%
PBT 529,338 324,469 412,739 439,669 391,533 338,393 225,787 15.24%
Tax -134,895 -88,061 -104,263 -106,934 -97,230 -84,206 -55,340 15.99%
NP 394,443 236,408 308,476 332,735 294,303 254,187 170,447 14.99%
-
NP to SH 394,443 236,408 308,476 332,735 294,303 254,187 170,447 14.99%
-
Tax Rate 25.48% 27.14% 25.26% 24.32% 24.83% 24.88% 24.51% -
Total Cost 1,198,813 1,328,572 1,182,591 946,593 890,490 793,163 535,884 14.34%
-
Net Worth 1,894,383 1,524,188 1,549,719 1,392,929 974,985 764,459 775,467 16.03%
Dividend
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
Div 123,824 59,231 113,867 105,169 89,277 136,105 88,668 5.71%
Div Payout % 31.39% 25.05% 36.91% 31.61% 30.34% 53.55% 52.02% -
Equity
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
Net Worth 1,894,383 1,524,188 1,549,719 1,392,929 974,985 764,459 775,467 16.03%
NOSH 255,307 253,651 250,893 249,735 201,027 152,891 154,168 8.76%
Ratio Analysis
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
NP Margin 24.76% 15.11% 20.69% 26.01% 24.84% 24.27% 24.13% -
ROE 20.82% 15.51% 19.91% 23.89% 30.19% 33.25% 21.98% -
Per Share
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
RPS 624.05 612.98 584.03 512.49 589.37 685.03 458.16 5.28%
EPS 154.50 92.60 120.83 133.29 146.40 166.25 110.56 5.73%
DPS 48.50 23.20 44.60 42.13 44.41 89.70 57.51 -2.79%
NAPS 7.42 5.97 6.07 5.58 4.85 5.00 5.03 6.68%
Adjusted Per Share Value based on latest NOSH - 249,735
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
RPS 312.12 306.58 292.10 250.62 232.10 205.18 138.37 14.50%
EPS 77.27 46.31 60.43 65.18 57.65 49.80 33.39 14.99%
DPS 24.26 11.60 22.31 20.60 17.49 26.66 17.37 5.72%
NAPS 3.7111 2.9859 3.0359 2.7288 1.91 1.4976 1.5192 16.03%
Price Multiplier on Financial Quarter End Date
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
Date 30/08/21 28/08/20 30/08/19 30/08/18 30/08/17 30/08/16 28/08/15 -
Price 12.06 9.04 15.00 15.10 12.48 14.98 12.18 -
P/RPS 1.93 1.47 2.57 2.95 2.12 2.19 2.66 -5.20%
P/EPS 7.81 9.76 12.41 11.33 8.52 9.01 11.02 -5.57%
EY 12.81 10.24 8.06 8.83 11.73 11.10 9.08 5.89%
DY 4.02 2.57 2.97 2.79 3.56 5.99 4.72 -2.63%
P/NAPS 1.63 1.51 2.47 2.71 2.57 3.00 2.42 -6.36%
Price Multiplier on Announcement Date
31/08/21 31/08/20 31/08/19 31/08/18 31/08/17 31/08/16 31/08/15 CAGR
Date 28/09/21 29/09/20 26/09/19 04/10/18 05/10/17 04/10/16 06/10/15 -
Price 11.88 10.60 14.96 15.86 12.80 14.60 13.58 -
P/RPS 1.90 1.73 2.56 3.09 2.17 2.13 2.96 -7.11%
P/EPS 7.69 11.45 12.38 11.90 8.74 8.78 12.28 -7.49%
EY 13.00 8.74 8.08 8.40 11.44 11.39 8.14 8.10%
DY 4.08 2.19 2.98 2.66 3.47 6.14 4.24 -0.63%
P/NAPS 1.60 1.78 2.46 2.84 2.64 2.92 2.70 -8.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment